Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05921565 · ClinicalTrials.gov registry record · NA
M-POWER Feasibility Study
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT05921565 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 26 participants.
The verdict
NCT05921565, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The purpose of this study is to test a new weight loss intervention designed for cancer survivors who have heart disease or cardiometabolic conditions. The investigators want to determine whether this study is feasible and acceptable to participants. The investigators also want to learn more about how cancer survivors take their medications.
Interventions
- BEHAVIORAL Interventional Behavioral Arm
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2023-11-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05921565
The ClinicalTrials.gov registry entry for NCT05921565 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Interventional Behavioral Arm is the first listed.
NCT05921565 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05921565 about?
NCT05921565 is a clinical study titled "M-POWER Feasibility Study". The purpose of this study is to test a new weight loss intervention designed for cancer survivors who have heart disease or cardiometabolic conditions. The investigators want to determine whether this study is feasible and acceptable to participants. The investigators also want to learn more about h...
What is the current status of trial NCT05921565?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2019-03-11. Estimated completion is 2023-11-08.
What interventions are being tested in trial NCT05921565?
The interventions under investigation include: Interventional Behavioral Arm (BEHAVIORAL).
Who is sponsoring clinical trial NCT05921565?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.